- Home
- DDS vs CORT Comparison
DDS vs CORT Comparison
Compare DDS & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DDS
- CORT
- Stock Information
- Founded
- DDS 1938
- CORT 1998
- Country
- DDS United States
- CORT United States
- Employees
- DDS N/A
- CORT N/A
- Industry
- DDS Department/Specialty Retail Stores
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- DDS Consumer Discretionary
- CORT Health Care
- Exchange
- DDS Nasdaq
- CORT Nasdaq
- Market Cap
- DDS 7.0B
- CORT 5.6B
- IPO Year
- DDS N/A
- CORT N/A
- Fundamental
- Price
- DDS $466.76
- CORT $55.31
- Analyst Decision
- DDS Sell
- CORT Strong Buy
- Analyst Count
- DDS 2
- CORT 4
- Target Price
- DDS $324.00
- CORT $75.25
- AVG Volume (30 Days)
- DDS 127.7K
- CORT 791.4K
- Earning Date
- DDS 02-24-2025
- CORT 02-13-2025
- Dividend Yield
- DDS 0.21%
- CORT N/A
- EPS Growth
- DDS N/A
- CORT 57.97
- EPS
- DDS 38.87
- CORT 1.26
- Revenue
- DDS $6,697,476,000.00
- CORT $628,555,000.00
- Revenue This Year
- DDS N/A
- CORT $46.29
- Revenue Next Year
- DDS $0.41
- CORT $17.09
- P/E Ratio
- DDS $12.01
- CORT $43.87
- Revenue Growth
- DDS N/A
- CORT 39.67
- 52 Week Low
- DDS $328.00
- CORT $20.84
- 52 Week High
- DDS $476.48
- CORT $62.22
- Technical
- Relative Strength Index (RSI)
- DDS 60.51
- CORT 58.22
- Support Level
- DDS $432.39
- CORT $49.00
- Resistance Level
- DDS $460.00
- CORT $52.17
- Average True Range (ATR)
- DDS 15.06
- CORT 1.76
- MACD
- DDS 0.41
- CORT 0.52
- Stochastic Oscillator
- DDS 100.00
- CORT 99.21
About DDS Dillard's Inc.
Dillard's Inc is an American fashion apparel, cosmetics, and home furnishings retailer. Its stores offer a large variety of merchandise and feature products from both national and exclusive brand sources. The company also operates a general contracting construction company, CDI Contractors. CDI Contractors' business includes constructing and remodelling stores for Dillards. The merchandise selections include exclusive brand merchandise such as Antonio Melani, Gianni Bini, Daniel Cremieux, Roundtree & Yorke, and private-label merchandise, among others. The company operates in two business segments; Retail Operations and Construction. The Retail Operations segment generates maximum revenue for the company.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.